Is There an Opportunity for Growth in the Antihypertensive Market?
This research service presents the findings on the antihypertensive market in
select Southern Africa Developing Countries (SADC). The market size and growth
of the total antihypertensive market is provided at total and country level.
These give an insight into the major factors that are driving the market,
together with main restrains that are limiting growth. The market size and
growth for the four main drug classes are also presented both at aggregate and
country level. At country level, a brief competitive overview is also provided
for the antihypertensive market and this highlights key suppliers in the
market and their respective market share. Key products that are top performing
for each key supplier are also presented.
Key Questions This Study Will Answer
What is the size of the antihypertensive market, is it expected to grow
and at what rate?
Which drug class is widely used and why? What is the expected growth rate?
What are the key drivers for growth? What are the main restraints that are
inhibiting growth?
Which companies are the key suppliers in each country? What are the key
success factors to gain market leadership?
In which country do opportunities exists?
Table of Contents
Table of Contents
1. Executive Summary
2. Market Overview
3. Total Antihypertensive Market
External Challenges: Drivers and Restraints
Forecast and Trends
Mega Trends and Industry Convergence Implications
4. The CEO's 360 Degree Perspective on the Antihypertensive Market
5. Zimbabwe Breakdown
6. Malawi Breakdown
7. Mauritius Breakdown
8. The Last Word
9. Appendix
Analysis of the Antihypertensive Market in Select SADC Countries published by Frost & Sullivan in September 25, 2012. This report price starts from US $ 7500.
